Where this was said
Story 4: Lizzo's Album Sells 2,649 Copies — The Full Post-Mortem
At 45:55 · chapter starts 44:49
Jackie drops the numbers: 2,649 first-week copies, 2.7 million on-demand streams, 650 units in week two, and zero charted singles — all reported by Rolling Stone using Luminate data. [1] — Jackie Oshry "2,649 album copies sold: Lizzo's new album 'Bitch' sold only 2,649 copies in its first week, according to music data company Luminate." 44:49 Claudia immediately names the elephant in the room: the music itself isn't good. She argues that artists with far worse scandals — Morgan Wallen, Chris Brown, Michael Jackson — survived commercially because their songs were simply too good to quit. Lizzo's weren't. Jackie adds a cultural layer: Lizzo's 2019 moment was a perfect alignment of messaging, sound, and zeitgeist that has since passed. Then Claudia delivers her most provocative thesis: Ozempic effectively ended the body-positivity movement by giving its followers an actual choice — and most took the drug. [2] — Claudia Oshry "Claudia argues that GLP-1 drugs like Ozempic quietly made Lizzo's body-positivity message irrelevant — not because people stopped believing…" 49:15 Trisha Paytas's recent GLP-1 journey is cited as a parallel case. The segment closes with a brief structural point about album economics (a successful release today is ~50,000 copies, not the millions of the CD era) and a lingering question about why Rolling Stone chose to publicize these particular numbers.
Lizzo's new album 'Bitch' sold only 2,649 copies in its first week, according to music data company Luminate.
Lizzo's new album 'Bitch' sold just 2,649 copies in its first week and failed to land a single song on the Billboard 200. Jackie and Claudia argue the real culprit isn't the lawsuit from her backup dancers, the label abandoning her, or even the streaming shift — it's simply that the music isn't good enough to overcome any of those headwinds.
Lizzo's album achieved only 2.7 million on-demand streams in its first week, a strikingly low figure for a Grammy-nominated artist.
In its second week, Lizzo's album sales dropped further to just 650 units, showing no recovery trajectory.
Claudia noted that a 'successful' album for a regular (non-superstar) artist is roughly 50,000 copies, not the millions of the CD era.
Not a single track from Lizzo's new album charted on the Billboard 200, compounding the commercial failure.
Claudia argues that GLP-1 drugs like Ozempic quietly made Lizzo's body-positivity message irrelevant — not because people stopped believing in it, but because when given an actual choice, most people who wanted to lose weight took it. The movement's most loyal followers opted out.
